FDA warns about Sanofi MS drug

The FDA is warning consumers about the risk of rare but serious cases of stroke and tears in the lining of arteries in the head and neck associated with Sanofi ’s multiple sclerosis drug, Lemtrada.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news